Q1: 2026-05-07 Earnings Summary

EPS of $0.24 beats by $0.00

|

Revenue of

$106.51M

(158.87% Y/Y)

beats by $14.41M

Ironwood Pharmaceuticals, Inc. ( IRWD ) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT

Company Participants

Greg Martini - Senior VP, CFO & Investor Relations

Thomas McCourt - CEO & Director

Tammi Gaskins - Senior Vice President & Chief Commercial Officer.

Michael Shetzline - Chief Medical Officer, Senior VP and Head of Research & Drug Development

Conference Call Participants

Mohit Bansal - Wells Fargo Securities, LLC, Research Division

Katherine Wang - Jefferies LLC, Research Division

Jason Butler - Citizens JMP Securities, LLC, Research Division

Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division

Tom Rosenfeld

Presentation

Operator

Thank you for standing by. My name is Liz and I'll be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals First Quarter 2026 Investor Update Conference Call.…